DWTXDogwood Therapeutics, Inc.
NAS · US · Healthcare · Biotechnology · dwtx.com
1.708USD+2.29%Mkt Cap: 57.45M USDP/E: 1.46Last update: 2026-06-01

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famci…

Indicators:|

Key Statistics

Company
Market Cap57.45M USD
Enterprise Value50.09M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-34.26M USD
Revenue/Share
Last Price1.708 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)1.46
P/E (Forward)-0.27
PEG
EV/EBITDA-1.75
EV/Revenue
P/S
P/B0.67
EPS (TTM)1.17
EPS (Forward)-6.37
52W Range
1.2805% of range9.500
52W High9.500 USD
52W Low1.280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-45.74%
ROA-37.99%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-15.62M USD
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt-6.36M USD
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.00
Current Ratio
Quick Ratio
Book Value/Sh2.518 USD
Cash/Share0.1950 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:25
Split DateOct 9, 2024
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)14.00 USD
Target Range12.00 USD15.00 USD
# Analysts3
Ownership
Shares Out.33.63M
Float5.07M
Insiders74.49%
Institutions10.97%
Short Interest
Short Ratio0.7d
Short % Float0.92%
Short % Out.0.32%
Shares Short108.42K
Short (prev mo.)46.58K
Technical
SMA 501.848 (-7.6%)
SMA 2004.016 (-57.5%)
Beta1.70
S&P 52W Chg27.94%
Avg Vol (30d)90.70K
Avg Vol (10d)57.84K
Technical Indicators
RSI (14)45.4
MACD-0.0132
MACD Signal-0.0243
MACD Hist.+0.0111
BB Upper2.002 USD
BB Middle1.704 USD
BB Lower1.405 USD
BB Width35.03%
ATR (14)0.1497 USD
Vol Ratio (20d)0.32x